Transfusion efficacy and influencing factors of patients transfused with different therapeutic doses of platelets: a comparative analysis

[Objective] To compare and analyze the efficacy of platelet transfusion in patients with different doses, and to analyze the risk factors for platelet transfusion refractoriness. [Methods] A total of 5 827 patients who received platelet transfusion in the PLA General Hospital from May 2023 to May 20...

Full description

Saved in:
Bibliographic Details
Main Authors: ZHU Jianling, CHENG Tingting, MA Chunya, FU Lihui, SHI Hongmei, YU Yang
Format: Article
Language:zho
Published: Institute of Blood Transfusion of Chinese Academy of Medical Sciences 2024-12-01
Series:Zhongguo shuxue zazhi
Subjects:
Online Access:https://www.cjbt.cn/thesisDetails#10.13303/j.cjbt.issn.1004-549x.2024.12.007&lang=en
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841557823086919680
author ZHU Jianling
CHENG Tingting
MA Chunya
FU Lihui
SHI Hongmei
YU Yang
author_facet ZHU Jianling
CHENG Tingting
MA Chunya
FU Lihui
SHI Hongmei
YU Yang
author_sort ZHU Jianling
collection DOAJ
description [Objective] To compare and analyze the efficacy of platelet transfusion in patients with different doses, and to analyze the risk factors for platelet transfusion refractoriness. [Methods] A total of 5 827 patients who received platelet transfusion in the PLA General Hospital from May 2023 to May 2024 were selected as the research subjects, among which 4 780 patients were transfused with 1 therapeutic dose of platelets, and 1 047 patients were transfused with 0.5 therapeutic dose of platelets, and the efficacy of platelet transfusion was compared between the two groups. The effects of gender, disease type, white blood cell count before transfusion, fever, number of platelet transfusions, and platelet antibodies on platelet transfusion refractoriness were analyzed using univariate analysis, and the independent risk factors affecting platelet transfusion refractoriness were further analyzed by multivariate logistic regression. [Results] Among 4 780 patients, 3553 (74.3%) were effective and 1 227 (25.7%) were ineffective. Among 1 047 patients, 0.5 platelet infusion was effective in 755 cases (72.1%) and ineffective in 292 cases (27.9%). There was no significant difference in the effective rate of platelet transfusion between the two groups (P>0.05). Univariate analysis showed that the therapeutic effect of platelet transfusion was related to age, the number of platelet transfusion, disease type, platelet antibodies and white blood cell count before transfusion (P<0.05), while age, gender, fever and blood type were not related to the therapeutic effect of platelet transfusion (P>0.05). The results of multi-factor analysis showed that age, white blood cell count >50×109/L, platelet transfusion times, disease type and platelet antibody were independent risk factors for ineffective transfusion (P<0.05). [Conclusion] There is no significant difference in the efficacy of platelet infusion with 0.5 therapeutic dose or 1 therapeutic dose. In addition, age, white blood cell count >50×109/L, the number of platelet transfusion, disease type and platelet antibodies were the factors affecting the ineffective platelet transfusion in group 2.
format Article
id doaj-art-1c2c0e9eaa954b30b021bab6560c7dab
institution Kabale University
issn 1004-549X
language zho
publishDate 2024-12-01
publisher Institute of Blood Transfusion of Chinese Academy of Medical Sciences
record_format Article
series Zhongguo shuxue zazhi
spelling doaj-art-1c2c0e9eaa954b30b021bab6560c7dab2025-01-06T09:43:02ZzhoInstitute of Blood Transfusion of Chinese Academy of Medical SciencesZhongguo shuxue zazhi1004-549X2024-12-0137121383138710.13303/j.cjbt.issn.1004-549x.2024.12.0071004-549X(2024)12-1383-05Transfusion efficacy and influencing factors of patients transfused with different therapeutic doses of platelets: a comparative analysisZHU Jianling0CHENG Tingting1MA Chunya2FU Lihui3SHI Hongmei4YU Yang5Department of Transfusion Medicine, First Medical Center, PLA General Hospital, Beijing 100853, ChinaDepartment of Transfusion Medicine, First Medical Center, PLA General Hospital, Beijing 100853, ChinaDepartment of Transfusion Medicine, First Medical Center, PLA General Hospital, Beijing 100853, ChinaDepartment of Transfusion Medicine, First Medical Center, PLA General Hospital, Beijing 100853, ChinaDepartment of Transfusion Medicine, First Medical Center, PLA General Hospital, Beijing 100853, ChinaDepartment of Transfusion Medicine, First Medical Center, PLA General Hospital, Beijing 100853, China[Objective] To compare and analyze the efficacy of platelet transfusion in patients with different doses, and to analyze the risk factors for platelet transfusion refractoriness. [Methods] A total of 5 827 patients who received platelet transfusion in the PLA General Hospital from May 2023 to May 2024 were selected as the research subjects, among which 4 780 patients were transfused with 1 therapeutic dose of platelets, and 1 047 patients were transfused with 0.5 therapeutic dose of platelets, and the efficacy of platelet transfusion was compared between the two groups. The effects of gender, disease type, white blood cell count before transfusion, fever, number of platelet transfusions, and platelet antibodies on platelet transfusion refractoriness were analyzed using univariate analysis, and the independent risk factors affecting platelet transfusion refractoriness were further analyzed by multivariate logistic regression. [Results] Among 4 780 patients, 3553 (74.3%) were effective and 1 227 (25.7%) were ineffective. Among 1 047 patients, 0.5 platelet infusion was effective in 755 cases (72.1%) and ineffective in 292 cases (27.9%). There was no significant difference in the effective rate of platelet transfusion between the two groups (P>0.05). Univariate analysis showed that the therapeutic effect of platelet transfusion was related to age, the number of platelet transfusion, disease type, platelet antibodies and white blood cell count before transfusion (P<0.05), while age, gender, fever and blood type were not related to the therapeutic effect of platelet transfusion (P>0.05). The results of multi-factor analysis showed that age, white blood cell count >50×109/L, platelet transfusion times, disease type and platelet antibody were independent risk factors for ineffective transfusion (P<0.05). [Conclusion] There is no significant difference in the efficacy of platelet infusion with 0.5 therapeutic dose or 1 therapeutic dose. In addition, age, white blood cell count >50×109/L, the number of platelet transfusion, disease type and platelet antibodies were the factors affecting the ineffective platelet transfusion in group 2.https://www.cjbt.cn/thesisDetails#10.13303/j.cjbt.issn.1004-549x.2024.12.007&lang=en0.5 therapeutic dose1 therapeutic doseplatelet transfusion efficacymultivariate analysis
spellingShingle ZHU Jianling
CHENG Tingting
MA Chunya
FU Lihui
SHI Hongmei
YU Yang
Transfusion efficacy and influencing factors of patients transfused with different therapeutic doses of platelets: a comparative analysis
Zhongguo shuxue zazhi
0.5 therapeutic dose
1 therapeutic dose
platelet transfusion efficacy
multivariate analysis
title Transfusion efficacy and influencing factors of patients transfused with different therapeutic doses of platelets: a comparative analysis
title_full Transfusion efficacy and influencing factors of patients transfused with different therapeutic doses of platelets: a comparative analysis
title_fullStr Transfusion efficacy and influencing factors of patients transfused with different therapeutic doses of platelets: a comparative analysis
title_full_unstemmed Transfusion efficacy and influencing factors of patients transfused with different therapeutic doses of platelets: a comparative analysis
title_short Transfusion efficacy and influencing factors of patients transfused with different therapeutic doses of platelets: a comparative analysis
title_sort transfusion efficacy and influencing factors of patients transfused with different therapeutic doses of platelets a comparative analysis
topic 0.5 therapeutic dose
1 therapeutic dose
platelet transfusion efficacy
multivariate analysis
url https://www.cjbt.cn/thesisDetails#10.13303/j.cjbt.issn.1004-549x.2024.12.007&lang=en
work_keys_str_mv AT zhujianling transfusionefficacyandinfluencingfactorsofpatientstransfusedwithdifferenttherapeuticdosesofplateletsacomparativeanalysis
AT chengtingting transfusionefficacyandinfluencingfactorsofpatientstransfusedwithdifferenttherapeuticdosesofplateletsacomparativeanalysis
AT machunya transfusionefficacyandinfluencingfactorsofpatientstransfusedwithdifferenttherapeuticdosesofplateletsacomparativeanalysis
AT fulihui transfusionefficacyandinfluencingfactorsofpatientstransfusedwithdifferenttherapeuticdosesofplateletsacomparativeanalysis
AT shihongmei transfusionefficacyandinfluencingfactorsofpatientstransfusedwithdifferenttherapeuticdosesofplateletsacomparativeanalysis
AT yuyang transfusionefficacyandinfluencingfactorsofpatientstransfusedwithdifferenttherapeuticdosesofplateletsacomparativeanalysis